
One Stop Solution Partner
One Partner,
Full Journey.
INCREASE provides integrated, end-to-end services that support healthcare innovations from research and development through to market access. Combining contract research organization (CRO) services, central laboratory capabilities, and regulatory expertise under one platform, INCREASE simplifies the development journey and reduces the complexity of managing multiple partners.
The full journey
From ideation to market access.
- Study Design
- Site Activation
- Trial Execution
- Data Management
- Market Access
End-to-end Capabilities
Study
Design
- Protocol aligned with lab & regulatory
- Feasibility based on real site data
- Regulatory strategy tailored to BPOM & regional requirements
End-to-end Capabilities
Site
Activation
- Parallel regulatory & site activation
- Pre-qualified network of clinical sites
- Ethics & regulatory submission processed simultaneously
End-to-end Capabilities
Trial
Execution
- Patient recruitment & site management
- Integrated CRO–lab coordination
- Centralized in-house sample management
End-to-end Capabilities
Data
Management
- Samples, laboratory results, and study documentation in one system.
- No third-party handover, no reconciliation between vendors.
- Unified, submission-ready dataset.
- Real-time data quality monitoring.
End-to-end Capabilities
Market
Access
- Regulatory submission support
- With CRO, laboratory, and data systems under one roof, submission packages come together faster and reach BPOM without waiting on external handovers
- Post-approval monitoring & lifecycle management
Why we win
Integration Drives
Better Outcomes
- Multiple vendors
- Fragmented data
- Risky international sample transport
- Misaligned execution
- Single partner
- Unified data flow
- Eliminates dependency on international sample transport
- End-to-end coordinated execution across CRO, lab, and regulatory
Better data · Faster timeline · Lower risk
Speed advantage
Faster
Study
Normal
6–9
months
INCREASE
3–6
months
- Early laboratory integration
- Sequential → parallel execution
- Investigator and site network ready
- Expert regulatory team
- Integrated study documentation
- Centralized project management
- Dedicated team with subject-matter experts in each field
- End-to-end services tailored to client needs
- Site and regional coverage across Indonesia
*Based on internal project benchmark. Actual timelines are estimates and may vary depending on study complexity and project requirements.
Our People
The People Behind INCREASE
From clinical research experts to regulatory specialists, our team is structured to deliver integrated solutions — from study design to market access.
Meet the full teamdr. Robby Hertanto
Chief Executive Officer
Apt. David Chen, PhD
Head of Finance, Accounting and Tax
Yuyus Kusnadi, PhD
Head of Clinical Operations
Apt. Rizki Tsari Andriani, PhD
Head of Laboratory Operations
Ns. Agus Gunadi (Nadi), M.Epid.
Clinical Project Manager
Heny Purwanti, M.Sc
Bio-analytical Lab Manager

Vision Mission | Core Values | Quality Policy






